GLP-1 receptor agonists (GLP-1Ras) have anti-inflammatory effects in the central nervous system, contrasting neuroinflammation in AD models, thereby improving cognitive dysfunctions. The gene discussed is GLP1R; the disease is Alzheimer disease.